ARRY
Price
$9.07
Change
-$0.00 (-0.00%)
Updated
Aug 25, 12:44 PM (EDT)
Capitalization
1.39B
73 days until earnings call
IMAB
Price
$5.23
Change
+$0.14 (+2.75%)
Updated
Aug 25, 11:28 AM (EDT)
Capitalization
415.65M
80 days until earnings call
Interact to see
Advertisement

ARRY vs IMAB

Header iconARRY vs IMAB Comparison
Open Charts ARRY vs IMABBanner chart's image
Array Technologies
Price$9.07
Change-$0.00 (-0.00%)
Volume$10.63K
Capitalization1.39B
I-MAB
Price$5.23
Change+$0.14 (+2.75%)
Volume$377
Capitalization415.65M
ARRY vs IMAB Comparison Chart in %
Loading...
ARRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IMAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ARRY vs. IMAB commentary
Aug 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARRY is a Buy and IMAB is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 25, 2025
Stock price -- (ARRY: $9.07 vs. IMAB: $5.09)
Brand notoriety: ARRY and IMAB are both not notable
ARRY represents the Alternative Power Generation, while IMAB is part of the Biotechnology industry
Current volume relative to the 65-day Moving Average: ARRY: 74% vs. IMAB: 157%
Market capitalization -- ARRY: $1.39B vs. IMAB: $415.65M
ARRY [@Alternative Power Generation] is valued at $1.39B. IMAB’s [@Biotechnology] market capitalization is $415.65M. The market cap for tickers in the [@Alternative Power Generation] industry ranges from $118.24B to $0. The market cap for tickers in the [@Biotechnology] industry ranges from $101.31B to $0. The average market capitalization across the [@Alternative Power Generation] industry is $1.88B. The average market capitalization across the [@Biotechnology] industry is $1.86B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARRY’s FA Score shows that 1 FA rating(s) are green whileIMAB’s FA Score has 0 green FA rating(s).

  • ARRY’s FA Score: 1 green, 4 red.
  • IMAB’s FA Score: 0 green, 5 red.
According to our system of comparison, ARRY is a better buy in the long-term than IMAB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARRY’s TA Score shows that 5 TA indicator(s) are bullish while IMAB’s TA Score has 5 bullish TA indicator(s).

  • ARRY’s TA Score: 5 bullish, 5 bearish.
  • IMAB’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both ARRY and IMAB are a good buy in the short-term.

Price Growth

ARRY (@Alternative Power Generation) experienced а +19.03% price change this week, while IMAB (@Biotechnology) price change was +4.52% for the same time period.

The average weekly price growth across all stocks in the @Alternative Power Generation industry was -0.38%. For the same industry, the average monthly price growth was +4.23%, and the average quarterly price growth was +34.18%.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.87%. For the same industry, the average monthly price growth was +19.72%, and the average quarterly price growth was +30.87%.

Reported Earning Dates

ARRY is expected to report earnings on Nov 06, 2025.

IMAB is expected to report earnings on Nov 13, 2025.

Industries' Descriptions

@Alternative Power Generation (-0.38% weekly)

The alternative power generation industry consists of companies that operate power facilities converting non-conventional forms of energy into electricity. These energy forms are alternatives to fossil fuels, and many of them are derived from natural resources. Alternative energy forms include solar, wind, hydro, and geothermal steam. A major purpose behind using alternative energy – also called ‘clean’ energy - is to address concerns related to the more conventional fossil fuels, such as the latter’s high carbon dioxide emissions which is often considered a factor in global warming. Alternative power generation has been gaining traction in recent years, and could grow further in the future. Large organizations like Google have invested substantially in wind and solar energy-powered electricity. Some of the prominent U.S. companies operating in the alternative power generation industry includes Ormat Technologies, Inc., TerraForm Power, Inc. and NextEra Energy Partners LP.

@Biotechnology (+2.87% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ARRY($1.39B) has a higher market cap than IMAB($416M). IMAB YTD gains are higher at: 498.824 vs. ARRY (50.166). IMAB has higher annual earnings (EBITDA): -46.92M vs. ARRY (-127.81M). ARRY has more cash in the bank: 377M vs. IMAB (169M). IMAB has less debt than ARRY: IMAB (3.68M) vs ARRY (694M). ARRY has higher revenues than IMAB: ARRY (1.17B) vs IMAB (0).
ARRYIMABARRY / IMAB
Capitalization1.39B416M333%
EBITDA-127.81M-46.92M272%
Gain YTD50.166498.82410%
P/E Ratio56.91N/A-
Revenue1.17B0-
Total Cash377M169M223%
Total Debt694M3.68M18,838%
FUNDAMENTALS RATINGS
ARRY: Fundamental Ratings
ARRY
OUTLOOK RATING
1..100
38
VALUATION
overvalued / fair valued / undervalued
1..100
93
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
28
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ARRYIMAB
RSI
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 4 days ago
81%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
81%
Bearish Trend 4 days ago
81%
Momentum
ODDS (%)
Bullish Trend 4 days ago
84%
Bullish Trend 4 days ago
77%
MACD
ODDS (%)
Bullish Trend 4 days ago
88%
Bullish Trend 4 days ago
85%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
79%
Bullish Trend 4 days ago
76%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
77%
Bullish Trend 4 days ago
79%
Advances
ODDS (%)
Bullish Trend 6 days ago
78%
Bullish Trend 4 days ago
77%
Declines
ODDS (%)
Bearish Trend 15 days ago
90%
Bearish Trend 18 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
82%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bearish Trend 4 days ago
82%
Bearish Trend 4 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ARRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IMAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VSMVX395.6116.09
+4.24%
Vanguard S&P Small-Cap 600 Val Idx Instl
PCSVX17.910.63
+3.65%
PACE Small/Medium Co Value Equity P
FGRAX51.800.74
+1.45%
Franklin Growth Opportunities A
LIRRX10.030.14
+1.42%
Lord Abbett International Value R3
FMIEX10.860.10
+0.93%
Wasatch Global Value Investor

IMAB and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMAB has been loosely correlated with VCYT. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if IMAB jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMAB
1D Price
Change %
IMAB100%
+8.07%
VCYT - IMAB
43%
Loosely correlated
+5.33%
INDP - IMAB
39%
Loosely correlated
+2.65%
ARRY - IMAB
31%
Poorly correlated
+8.10%
ALT - IMAB
30%
Poorly correlated
+0.28%
AXON - IMAB
29%
Poorly correlated
+0.36%
More